Ebola: first successful vaccine trials

According to media reports, the new vaccine, developed by the specialists from GlaxoSmithKline (GSK), was successfully tested on humans. For example, in the United States, it was injected to twenty volunteers. Scientists say the results of the research are "encouraging". Thus, Ebola can be defeated. After receiving this drug, body begins to fight the disease, joinfo.ua reports.

None of the vaccinated patients experienced serious side effects, and all the bodies began to produce antibodies. Scientists report that antibodies were produced more actively in the group of patients that was given a large dose of the drug.

At the same time, doctors reported that the vaccine trials would take place in four stages. The first stage is complete, the second and the third ones will be held in West Africa. Then the scientists will determine the level of vaccine safety.

As previously reported, the new vaccine developed to fight this dangerous disease, may be available in 2015.

So far, Ebola took the lives of about six thousand people. There were already recorded about 16,000 cases of infection by the deadly virus.